Malignant mesothelioma in rare sites: two case reports

Qiguang Du1, Jialu Guo2, Zi Zhu3

  • 1Department of Breast Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Frontiers in Oncology
|December 15, 2025
PubMed
Summary

Peritoneal mesothelioma responded well to chemo-immunotherapy, achieving a complete response. Malignant pleural mesothelioma (MPM) showed platinum resistance, highlighting the need for site-specific treatments.